Surgical Treatment of Hydatid Liver Disease
NCT05989516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72
Last updated 2023-08-29
Summary
The goal of this observational study is to show that cyst extraction with pericyst reduction and omentopexy is a suitable treatment for liver hydatid disease caused by E.Granulossus with a low rate of complication and recurrence.
Conditions
- Hydatid Cyst, Hepatic
Sponsors & Collaborators
-
University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje
lead OTHER
Principal Investigators
-
Elena Zafirovikj, MD · UHSD St. Naum Ohridski
Eligibility
- Min Age
- 16 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2022-02-01
- Completion
- 2023-03-01
Countries
- North Macedonia
Study Locations
More Related Trials
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
NCT07205471 ·Status: RECRUITING ·Phase: NA
-
Octreotide in Severe Polycystic Liver Disease
NCT00426153 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fecal Microbial Transplantation in Severe Alcoholic Hepatitis
NCT04758806 ·Status: UNKNOWN ·Phase: PHASE3
-
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
NCT03069339 ·Status: UNKNOWN ·Phase: NA
-
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4
-
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT06755541 ·Status: RECRUITING ·Phase: PHASE3
-
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
NCT05106972 ·Status: RECRUITING ·Phase: NA
-
Faecal Microbiota Transplantation for Liver Cirrhosis
NCT04932577 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
NCT02021110 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
Everolimus and LongActing Octreotide Trial in Polycystic Livers
NCT01157858 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
NCT00295607 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis
NCT05285592 ·Status: UNKNOWN ·Phase: NA
-
Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
NCT01315795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hepatocyte Matrix Implant Study
NCT00935454 ·Status: UNKNOWN ·Phase: PHASE1
-
A Hepatitis B With Hepatic Steatosis Study
NCT02392598 ·Status: UNKNOWN
-
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
NCT01766713 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients
NCT03963921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.
NCT02868164 ·Status: WITHDRAWN ·Phase: NA
-
A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.
NCT03091010 ·Status: UNKNOWN ·Phase: NA
-
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NCT06755151 ·Status: RECRUITING ·Phase: PHASE3
-
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
NCT06591455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study
NCT02469272 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF
NCT02946554 ·Status: COMPLETED ·Phase: PHASE2